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Abstract
The human oral microbiome has been known to show strong association with various oral diseases 
including oral cancer. This study attempts to characterize the community variations between 
normal, oral potentially malignant disorders (OPMD) and cancer associated microbiota using 16S 
rDNA sequencing.  Swab samples were collected from three groups (normal, OPMD and oral 
cancer) with nine subjects from each group. Bacteria genomic DNA was isolated in which full 
length 16S rDNA were amplified and used for cloned library sequencing. 16S rDNA sequences 
were processed and analysed with MOTHUR. A core oral microbiome was identified consisting 
of Firmicutes, Proteobacteria, Fusobacteria, Bacteroidetes and Actinobacteria at the phylum level 
while Streptococcus, Veillonella, Gemella, Granulicatella, Neisseria, Haemophilus, Selenomonas, 
Fusobacterium, Leptotrichia, Prevotella, Porphyromonas and Lachnoanaerobaculum were detected at 
the genus level.  Firmicutes and Streptococcus were the predominant phylum and genus respectively. 
Potential oral microbiome memberships unique to normal, OPMD and oral cancer oral cavities were 
also identified.  Analysis of Molecular Variance (AMOVA) showed a significant difference between 
the normal and the cancer associated oral microbiota but not between the OPMD and the other two 
groups.  However, 2D NMDS showed an overlapping of the OPMD associated oral microbiome 
between the normal and cancer groups.  These findings indicated that oral microbes could be potential 
biomarkers to distinguish between normal, OPMD and cancer subjects.
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ORIGINAL ARTICLE
INTRODUCTION
Oral cancer is a subset of head and neck cancer 
which is a type of cancer that occurs in the oral 
cavity affecting the lips, tongue,  gingiva, floor 
of mouth, palate and other related structures 
(International Classification of Diseases 10th 
edition codes C00-06).1,2
 Globally, it was estimated to be the 15th most 
common cancer with higher incidences among 
males in 2012.3 The estimated incidence and 
death from oral cancer saw a global increment 
of 14.2% and 13.9% respectively from 2008 
to 2012.3,4  Two-thirds of the cases occurred in 
developing countries and it is a major persistent 
health issue in parts of South Central Asia and 
South East Asia, where it was estimated to be 
one of five most common cancer between 2008 
and 2012.3-5  In parts of these regions, oral cancer 
was shown to comprise up to 40% of all cancer 
cases.6  In high risks countries such as Papua New 
Guinea, Pakistan, Maldives, Sri Lanka and India, 
it was one of the three most common cancers.3
 In Malaysia, oral cancer is the third most 
common head and neck cancer, affecting the 
elderly population and with equal risk for both 
genders.7 It is most common among Indians 
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regardless of different subsites such as mouth 
and tongue.8,9
 Oral cancer is a persistent health issue due to 
its asymptomatic early stages and the absence of 
reliable diagnostic techniques.10  These factors 
have been contributed to the late detection 
of advanced cancer stages thereby resulting 
in reduced effectiveness of treatment and the 
post-surgery life quality as well as poor survival 
rate. 5,11-13  Early  detection and treatment could 
cure the cancer, improve the survival rate, and 
improve the quality of life due to less debilitating 
treatments.14,15
 Tobacco, alcohol and betel quid are known 
oral cancer risk factors; emerging aetiological 
factors include bacterial, viral or fungal 
infections.16-18  About 20% of the human tumours 
are preceded by infections or inflammations 
while many oral cancers were found to develop 
from oral potentially malignant disorders 
(OPMD)  such as leukoplakia, erythroplakia 
and erythroleukoplakia.19-21  These lesions are 
associated with chronic inflammation, which has 
been observed at various stages of oral cancer 
and epithelial dysplasia, which is known to be 
associated with risk of malignancy.22
 In addition to cancer associated inflammation, 
certain microbial species have been found to 
be cancer associated.  For instance, Prevotella 
melaninogenica, Capnocytophaga gingivalis and 
Streptococcus mitis appear to be significantly 
elevated in tumour tissues compared to normal 
counterparts from the same patient.23  Besides 
that, the salivary microbiome of oral cancer 
patients formed a distinct cluster separated 
from the normal group in a study using the 
Denaturing Gradient Gel Electrophoresis 
(DGGE) fingerprint technique.24 It has been 
suggested that this association between oral 
cancer and microbiome can be exploited for the 
development of diagnostic tools  since bacteria 
is able to selectively bind to and colonize 
mucosal surfaces similar to a “lock and key” 
mechanism.23,25
 Some oral tumours are derived from oral 
potentially malignant disorders (OPMD), which 
is a group of disorders described as genetically 
mutated oral epithelial cells with or without 
clinical and histomorphological abnormal 
appearances that are malignant transformable.26 
OPMD with subtle abnormalities present 
diagnostic challenges while the potential 
for multifocal cancer development not only 
complicates prognosis but also reduces 
treatment effectiveness.27-29  The associated oral 
microbiome was not addressed in previous 
studies  which otherwise could uncover OPMD 
associated oral microbes that have the potential 
to be biomarkers for the detection of genetically 
abnormal oral mucosa  prior to the early oral 
cancer stage.15,23-26
 Therefore, this study aims to identify oral 
cancer associated microbiota variations through 
the cross sectional comparison of the normal, 
OPMD and cancer 16S cloned libraries with the 
intention to identify OPMD and cancer associated 
microbial profiles with potential medical value. 
The results suggest several oral microbial species 
are associated with certain oral clinical states. 
MATERIALS AND METHODS
Subject recruitment
Ethical approvals for the recruitment of normal 
volunteers and oral cancer patients were granted 
by University Tunku Abdul Rahman (UTAR) 
Scientific & Ethical Review Committee (U/
SERC/03/2011) and Faculty of Dentistry Medical 
Ethics Committee of the University of Malaya 
(UM) respectively (DF OP1208/0056(L)). 
Normal (n=9) subjects were recruited, with 
written informed consent, from UTAR while 
OPMD (n=9) and cancer (n=9) samples were 
collected from the biobank of Oral Medicine/
Oral Surgery Clinic at the Faculty of Dentistry 
(coordinated by the Oral Cancer Research and 
Coordinating Center (OCRCC), UM).  Normal 
subjects and patient samples were selected based 
on the criteria in Table 1. The size of all subject 
groups was standardized according to the number 
of matched OPMD samples that can be collected 
from the biobank.
 Two swabs (Millipore) were collected from the 
normal subject by rubbing against oral regions 
that cover the entire oral cavity (Table 2). Swabs 
were dipped into 400 µL of preservation buffer 
(50 mM Tris, pH 8.0, 50 mM EDTA, 50 mM 
sucrose, 100 mM NaCl, 1% SDS) and stored at 
ambient temperature prior to DNA extraction.30
DNA extraction
DNA extraction from swabs was done with a 
commercial kit (EURx) with some modifications 
to the manufacturer’s protocol to compensate 
for the addition of the preservation buffer as 
the starting material. Briefly, the volume of 
proteinase K, Sol S buffer and absolute ethanol 
were doubled while the incubation period 
of Proteinase K digestion was prolonged to 
overnight with shaking prior to steps involving 
the spin column.
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 DNA yield and purity were determined 
spectrophotometrically with a NanoPhotometer 
(IMPLEN).  The extracted DNA was stored at 
-80°C prior to downstream molecular processes.
16S PCR
The D88 (GAG AGT TTG ATY MTG GCT 
CAG) and E94 (GAA GGA GGT GWT CCA 
RCC GCA) primer pair was selected for use in 
this study to produce near full length 16S PCR 
amplicons based on their extensive usage in 
oral microbiome related studies.25,31-33  The PCR 
mixture contained around 35 ng DNA template, 
1X MgCl2 free buffer, 0.5 mM MgCl2, 0.5 µM 
of each forward and reverse primer, 0.2 mM 
of dNTPs mixture and 1.5 U Taq polymerase 
(Intron Biotechnology) in 50 µL.  All PCRs 
were carried out in the Veriti® 96-Well Thermal 
Cycler (Applied Biosystems) with 8 minutes of 
denaturation at 95ºC, followed by 25 cycles of 
denaturation at 95ºC (45 seconds), annealing at 
63ºC (60 seconds) and extension at 72ºC (90 
seconds), and a final 72ºC extension step for 10 
minutes.  16S PCR amplicons were examined 
with 1% agarose gel and purification using the 
MEGAquick-spin (iNtRON).
16S cloned library
Purified 16S PCR amplicons were cloned into 
pSTBlue-1 AccepTor Vector (Novagen) which 
was introduced into NovaBlue Singles™ 
Competent Cells according to the manufacturer’s 
protocol.  Cloned libraries were screened for the 
correct insert size of approximately 1.5kb with 
colony PCR prior to further analysis.
RFLP analysis and DNA sequencing
Cloned libraries were screened for distinct RFLP 
patterns with MspI and HhaI digestion for 1 
hour at 37ºC (Thermo Scientific).  Colonies with 
similar RFLP patterns were grouped together 
and the amount of colonies per RFLP group 
was used as abundance data.34 
 Transformed bacteria were cultured overnight 
and plasmid was extracted using High-Speed 
Plasmid Mini Kit (Geneaid) according to the 
manufacturer’s protocol.  All purified plasmid 
were sent to Bioneer Inc. for partial 16S rDNA 
sequencing that targets variable regions from V6 
to V9. 
 The partial 16S sequences obtained in this 
study have been deposited in the GenBank 
database under the accession number KP294530 
to KP294905.
Bacteria sequence identification and cloned 
library analysis
16S primer sequences were trimmed with 
Sequence Scanner 1.0 (Applied Biosystem) and 
were searched against the Human Microbiome 
Project Data Analysis and Coordination Center 
(HMP-DACC) which is available at http://www.
TABLE 1: Selection criteria
Inclusion criteria Groups Exclusion criteria
•	 Nationality	is	Malaysia	 All		 •	 Currently	having	malaise,	pregnancy	or		 	
•	 Minimum	age	of	20	years	old	 	 	 lactation
•	 Minimum	teeth	number	of	20	 	 •	 Infected	with	HIV
	 	 	 •	 Under	antibiotic	medication	within	the	past		
    3 months
	 	 	 •	 Involve	surgery,	chemotherapy	or	radiation		
    treatment within the past 1 month
	 	 Normal	 •	 Currently	with	gingival	health	issues	such			
    as ulcers and inflammations
•	 Diagnosed	with	OPMD		 OPMD	and	 •	 Feel	discomfort	during	sampling	procedures
 or cancerous lesions Oral Cancer  and withdraw from volunteering
TABLE 2: Selected oral regions for swab sampling 
Swabs Oral regions
1	 Tongue,	mouth	floor	and	lower	gingival
2	 Buccal,	soft	and	hard	palate	as	well	as	upper	gingival
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hmpdacc.org/resources/blast.php. Representative 
sequences were assigned to bacteria species with 
the highest bit score and lowest E-values.
 All representative sequences were processed 
using the MOTHUR software with some 
modifications.35 
Diversity estimation
Rarefaction curve and library coverage were 
calculated using the “rarefaction.single” and 
“collect.single” commands respectively together 
with Shannon and inverse Simpson indexes with 
the MOTHUR software. Shannon index were 
converted to effective species number (Table 3)
while the value of inverse Simpson index 
remained unchanged since it is the effective 
species number of itself.36
Community comparisons
Common Operational Taxonomic Units (OTU) 
that can be found across all subject groups 
were identified.  Besides, shared OTUs that are 
overlapped across any two subject groups as 
well as unique OTUs that can be found in one 
subject group were also tabulated.
 Individual cloned libraries were organized 
based on RFLP abundance records and 
normalized prior to NMDS ordination and 
AMOVA.  NMDS ordination was used to 
illustrate the similarities between different 
community structures which was calculated 
using MOTHUR software and plotted in R 
language environment using rgl package.37,38 
The significant difference of genetic diversity 
between pooled and within two communities 
was tested with AMOVA using the MOTHUR 
software.39
Phylogenetic analysis
Representative sequences were aligned by 
ClustalW with some 16S reference sequences 
from NCBI Nucleotide database.  Phylogenetic 
tree was generated by Neighbour Joining method 
using Mega 6.0 software.40
RESULTS
Demographic data of subjects
The subject groups consisted of Malay, Chinese 
and Indian ethnicities. The male to female ratio 
of the normal and cancer group was almost 
equal while there were more female OPMD 
patients (Table 4).  The average age of the cancer 
group was the highest, followed by the OPMD 
group and finally the normal group (Table 4). 
The smoking and drinking habit of all three 
subject groups were almost similar (Table 4). 
The OPMDs were confirmed histologically to 
be epithelial dysplasia while the oral cancer 
was confirmed histologically to be squamous 
cell carcinoma. 
TABLE 3: Formulae
Calculations Formula Symbol descriptions
Good’s	coverage	 (1-(n/N))100	 n	is	the	singletons	amount	while	N	is	the		 	
	 	 	 total	amount	of	OTUs
Shannon	Index	 -Σp
i
lnp
i
	 p
i
	is	the	ratio	of	specific	OTUs
Effective	species	number	of	 e^D
Shannon	
D
Shannon
	is	the	Shannon	index	
Shannon	index	
Simpson	Index	 Σp
i
2 p
i
	is	the	ratio	of	specific	OTUs
Effective	species	number	of	 1/D
Simpson	
D
Simpson
	is	the	Shannon	index	
Simpson	index	
TABLE 4: Subject demographic data
Subject groups Normal OPMD Cancer 
Gender:	 	    
	 Male	 4	 2	 4	 	
	 Female	 5	 7	 5	 	
Average	age	 40	 54	 60	
Smoking	habit	 1	 1	 2	
Drinking habit 0 1 1 
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Diversity metrics
The plateau stage of rarefaction curves (Fig. 1) 
and Good’s coverage of around 97% (Table 5) 
indicated that the number of colonies screened 
was sufficient to represent the normal, OPMD 
and cancer cloned libraries. 
 The effective species number of both Shannon 
and Simpson indexes were highest for the cancer 
group, followed by OPMD and finally the normal 
group (Table 5).  The species richness was the 
highest in the OPMD group and similar between 
the normal and cancer group (Table 5).
Bacterial profiles of normal, OPMD and cancer 
associated oral conditions
A total of five bacteria phyla were detected 
in all subject groups, with Firmicutes as the 
predominant phylum followed by Proteobacteria, 
Fusobacteria, Bacteroidetes and Actinobacteria 
(Fig. 2).  Certain phyla was found to be of higher 
abundance in particular oral condition (Fig. 2). 
 Twelve bacterial genera were found across 
all subject groups with Streptococcus being the 
predominant genus (Fig. 3). Veillonella, Gemella, 
Granulicatella and Neisseria form another 
portion of this common oral microbiome fraction 
with a total relative abundance ranging between 
27.3% to 32.2% (Fig. 3).  The remaining seven 
bacterial genera of Haemophilus, Selenomonas, 
Fusobacterium, Leptotrichia, Prevotella, 
Porphyromonas and Lachnoanaerobaculum 
only constitute a small proportion with a total 
relative abundance of less than 5% (Fig. 3). 
The relative abundance of Streptococcus and 
Veillonella were higher in the normal group while 
the relative abundance of Neisseria, Gemella and 
Granulicatella were higher in the patient groups 
(Fig. 3). 
 The total amount of bacterial species identified 
in this study is about 80 species, comparable with 
TABLE 5: Good’s coverage, species richness and effective species number of Shannon and 
Simpson indexes
Groups Good’s  Species Effective species number Inverse
 coverage, % richness of Shannon Index  Simpson Index
Normal 97.22 29 3.67 2.15
OPMD 96.96 35 4.96 2.66
Cancer 98.05 28 4.99 2.72
FIG. 1: Rarefaction curve of normal, OPMD and cancer groups.  Normal associated group symbolized as green 
triangles, OPMD associated group symbolized as blue squares and cancer associated communities sym-
bolized as red squares
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previous similar study.15  Some bacterial species 
were unique to a single oral conditions and some 
were found shared between 2 oral conditions. 
Of these, several bacterial species were found 
to have consistent association to certain oral 
conditions previously reported (Table 6). 
Association between bacteria phylogenetic 
groups and oral conditions
The phylogenetic trees (Figs. 4a-4f) revealed 
that bacteria groups were associated to normal 
and diseased oral clinical samples.  Besides, four 
unclassified OTUs were identified since they did 
not cluster with any closest reference sequences. 
Two were closely related to Ruminococcaceae 
(Fig. 4a), one was closely related to Clostridiales 
(Fig. 4b) while one was closely related to 
Veillonellaceae (Fig. 4a). 
 Bacteria groups that have association to only 
normal oral conditions were mainly identified 
in the Firmicutes phyla and they included the 
predominant Streptococcus and Veillonella that 
had higher relative abundance in the normal oral 
cavity, and Lachnospiraceae that was detected 
only in the normal condition (Figs. 4a & 4b).
 Bacteria groups that showed an association 
with only OPMD or cancer or both diseased 
oral conditions were found across all bacteria 
FIG. 2:  The relative abundance of 5 major bacteria phyla in normal, OPMD and cancer groups. Normal 
associated group symbolized as green triangles, OPMD associated group symbolized as blue 
squares and cancer associated communities symbolized as red squares
FIG. 3: The relative abundance of common bacteria genera that were found in all subject groups. Normal as-
sociated group symbolized as green triangles, OPMD associated group symbolized as blue squares and 
cancer associated communities symbolized as red squares
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TABLE 6:  Bacteria Species or Groups identified to have consistent association to certain oral 
health conditions in this study and previous published studies
Bacteria Species / Groups Association to oral  References
identified in the current study health conditions 
Normal 
Eubacterium saphenum* normal saliva Mager et al 200523
Lactobacillus iners* NT tissues Pushalkar et al 201215
Selenomonas sputigena* NT Pushalkar et al 201215
Actinomyces odontolyticus cancer saliva Mager et al 200523
Lautropia mirabilis isolated from mouth of HIV Rossman et al 199860 
 infected patient 
Stomatobaculum logum isolated from oral cavity GIDEON database56
Capnocytophaga leadbetteri isolated from oral cavity GIDEON database56
Lachnoanaerobaculum saburreum isolated from dental plaque GIDEON database56
Normal – OPMD  
Prevotella melaninogenica, T; NT; normal saliva Hooper et al 200725;
Prevotella veroralis  Iwamoto et al 201061;  
  Pushalkar et al 201215
Oribacterium sinus N/A 
Selenomonas noxia N/A 
OPMD  
Megasphaera micronuciformis T Pushalkar et al 201215
Prevetella nigrescens cancer saliva Mager et al 200523; 
  Pushalkar et al 201124
Eubacterium infirmum T Pushalkar et al 201215
Lactobacillus fermentum T Pushalkar et al 201215
Peptostreptococcus stomatis T Pushalkar et al 201215
Lactobacillus salivarius oral probiotic Iwamoto et al 201061
Prevotella multiformis periodontitis Sakamoto et al 200562
Actinomyces urogenitalis N/A 
Bacteroides clarus N/A 
Rothia aeria N/A 
Peptococcus niger N/A 
OPMD – Cancer  
Rothia mucilaginosa*, cancer saliva Pushalkar et al 201124
Rothia dentocariosa* 
Catonella morbi* T Pushalkar et al 201215
Prevotella pallens NT tissues Pushalkar et al 201215
Aggregatibacter segnis isolated from saliva of HIV  Li et al 201463
 infected patients 
Haemophilus paraphrohaemolyticus  N/A 
Haemophilus haemolyticus N/A 
Abiotrophia defective N/A 
Cancer  
Camplylobacter showae* T Pushalkar et al 201215
Capnocytophaga sputigena N/A 
Parvimonas micra NT Pushalkar et al 201215
Prevotella salivae NT Pushalkar et al 201215
Corynebacterium matruchotii N/A 
Normal – Cancer  
Campylobacter gracilis oral lichen planus Ertugrul et al 201364 
Symbols: * – bacterial species with consistent affiliation with particular oral condition; T – tumour tissues; NT 
– non-tumour tissues; N/A – information not available 
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	Streptococcus	[N]
 OTU13-P23-60-T7
 OTU13-P27-26-SP6
 OTU13-P19-52-T7
 OTU13-P02b-03-SP6
 Abiotrophia defectiva
	Gemella
 Staphylococcus lugdunensis
	Granulicatella
[P-C]
 Lactobacillus salivarius
 OTU50-P15-54-T7
 Lactobacillus fermentum
 OTU28-P16-05-T7
 Lactobacillus iners
 OTU40-P06-12-T7
Lactobacillus	[N-P]
Bacilli	Class
	Clostridiales	Order
 Desulfotomaculum peckii
 OTU41-P14-20-SP6
 Peptococcus niger
[P]
 Acetivibrio cellulolyticus
 Clostridium thermosuccinogenes
 OTU51-P24-24-SP6
 OTU32-P01a-38-T7
Ruminococcaceae	Family	[N-P]
 OTU09-P01a-33-T7
 OTU09-P21b-08-SP6
 Selenomonas infelix
 OTU09-P09-40-SP6
 OTU09-P02a-23-SP6
 OTU09-P14-53-SP6
 Selenomonas sp. oral taxon 149
 OTU09-P15-50-SP6
 Selenomonas noxia
 OTU25-P01a-12-SP6
 OTU25-P15-55-SP6
Selenomonas	[M]
 Pectinatus frisingensis
 Anaerovibrio lipolyticus
 OTU52-P15-25-T7 ***
 OTU37-P01a-48-T7
 Selenomonas sputigena
[N-P]
 Megasphaera micronuciformis
 OTU15-P19-57-SP6
 OTU15-P14-34-SP6
 OTU15-P15-17-T7
 OTU15-P14-07-SP6
[P]
	Veillonella	[N]
Veillonellaceae	Family
99
57
22
100
100
39
97
18
52
28
100
100
100
52
58
97
69
28
98
90
39
96
56
58
94
68
57
57
93
69
100
98
100
61
59
49
75
69
48
56
100
100
90
100
64
29
45
0.01
a.  Firmicutes Phylum
b.  Clostridiales Order of the Firmicutes Phylum
556
557
558
559
 OTU23-P01a-22-T7
 OTU23-P06-37-SP6
 Eubacterium saphenum
 Eubacterium infirmum
 OTU43-P14-29-SP6
 OTU45-P13-25-SP6
 Peptostreptococcus stomatis
[N-P]
 OTU42-P26-34-T7
 Parvimonas micra
[C]
 Parvimonas sp. oral taxon 110
 Parvimonas sp. oral taxon 393
 Defluviitalea saccharophila
 Vallitalea pronyensis
 OTU35-P22-57-SP6 *** [C]
 Catonella morbi
 OTU39-P19-41-SP6
[P-C]
 Oribacterium sinus
 OTU22-P03-10-T7
 OTU22-P13-57-T7
[N-P]
 Lachnospiraceae bacterium ACC2
 OTU26-P03-38-T7
[N]
 OTU36-P09-28-T7
 Lachnoanaerobaculum saburreum
 Lachnoanaerobaculum sp. OBRC5-5
 OTU12-P13-16-SP6
 Lachnoanaerobaculum umeaense
 OTU12-P14-14-SP6
 OTU12-P06-24-T7
 Lachnoanaerobaculum orale
 OTU12-P21a-49-T7
Lachnoanaerobaculum	[M]
100
50
100
92
100
97
96
61
100
42
84
100
83
100
100
49
96
84
44
56
60
50
68
99
81
55
46
83
0.01
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 OTU10-P11a-28-SP6
 OTU10-P17-03-T7
 OTU10-P02a-61-SP6
 Leptotrichia shahii
 OTU10-P03-08-T7
 OTU10-P09-29-T7
 Leptotrichia hofstadii
 OTU30-P06-06-T7
 Leptotrichia goodfellowii
 OTU18-P02b-15-T7
 OTU18-P09-57-T7
 OTU18-P23-21-SP6
Leptotrichia	[M]
 Fusobacterium periodonticum
 OTU07-P07-Y-T7
 OTU07-P15-32-SP6
 OTU07-P16-02-SP6
 Fusobacterium nucleatum subsp. animalis
 OTU07-P01a-26-SP6
 OTU07-P06-03-SP6
 OTU07-P04-18-T7
 OTU07-P23-35-SP6
 Fusobacterium nucleatum subsp. polymorphum
 OTU07-P02a-36-T7
 OTU07-P04-29-T7
 OTU07-P02a-75-T7
 OTU07-P23-27-T7
Fusobacterium	[M]
77
98
50
99
47
93
61
94
100
85
85
84
81
80
76
41
20
15
18
75
48
53
100
0.01
 Corynebacterium matruchotii
 OTU49-P21a-24-SP6
[C]
 Actinomyces sp. oral taxon 175
 OTU48-P04-59-T7
 Actinomyces urogenitalis
 OTU38-P13-38-T7
 Actinomyces odontolyticus
 OTU46-P03-48-SP6
Actiomyces	[N-P]
 OTU53-P17-41-T7
 Rothia aeria
 OTU14-P02a-02-SP6
 Rothia mucilaginosa
 OTU14-P02a-41-SP6
 OTU14-P13-28-SP6
 OTU14-P29-14-T7
 Rothia dentocariosa
Rothia	[P-C]
100
100
97
48
100
86
100
43
95
95
96
100
100
0.01
c.  Actinobacteria Phylum
560
561
d.  Fusobacteria Phylum
562
563
e.  Proteobacteria Phylum
564
565
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 Capnocytophaga sputigena
 OTU21-P02a-18-T7
 OTU21-P02a-49-SP6
 Capnocytophaga leadbetteri
 OTU34-P09-25-SP6
Capnocytophaga	[N-C]
 OTU17-P05-30-SP6
 OTU17-P19-30-T7
 OTU17-P27-13-T
 OTU31-P22-31-SP6
 Porphyromonas gingivalis
Porphyromonas	[M]
 Bacteroides clarus
 OTU33-P12-11-SP6
[P]
 OTU29-P14-42-T7
 Prevotella multiformis
 OTU44-P21a-18-T7
 Prevotella salivae
 OTU47-P19-07-SP6-E683F
 Prevotella nigrescens
 OTU20-P22-17-T7
 Prevotella pallens
 OTU16-P13-01-T7
 OTU16-P01a-40-SP6
 Prevotella melaninogenica
 OTU16-P19-43-SP6-E683F
 Prevotella veroralis
Prevotella	[P]
Bacteroidales	Order
79
100
99
100
83
98
97
100
80
83
100
100
100
83
58
66
65
99
43
81
75
100
98
0.02
f.  Bacteroidetes Phylum
564
565
FIG. 4:  NJ tree was generated based on ClustalW alignment with 1000 bootstraps. The 16S reference sequences 
were selected based on top results with lowest E-values from HMP-DACC and NCBI 16S nucleotide 
databases. The sequences were clustered into five bacteria phyla which were Firmicutes (4a and b), 
Actinobacteria (4c), Fusobacteria (4d), Proteobacteria (4e) and Bacteroidetes (4f). Bacteria groups as-
sociated to different status of clinical samples such as normal were donated as [N], normal and OPMD 
as [N-P], OPMD as [P], OPMD and cancer as [P-C], cancer as [C], normal and cancer as [N-C] and all 
three groups as [M]
TABLE 7: AMOVA based on V6-V9 regions of 16S rDNA which spans 751bp 
Groups Source of variations SS Df MS Fs p-value
N-O-C Among 0.1445 2 0.0723 3.0470 <0.05
	 Within	 0.4980	 21	 0.0237	  
	 Total	 0.6426	 23	   
      
N-O Among 0.0335 1 0.0335 1.4775 0.261
	 Within	 0.3403	 15	 0.0227	  
	 Total	 0.3739	 16	   
      
O-C Among 0.0414 1 0.0414 1.5798 0.227
	 Within	 0.3668	 14	 0.0262	  
	 Total	 0.4082	 15	   
      
N-C Among 0.1491 1 0.1491 6.7081 <0.05
	 Within	 0.2890	 13	 0.0222	  
	 Total	 0.4381	 14	   
Abbreviations: N-O-C: normal, OPMD and cancer groups; N-O: normal and OPMD groups; O-C: OPMD and 
cancer groups; N-C: normal and cancer groups
phyla with the exception of Fusobacteria. 
Firmicutes and Bacteroidetes were found to 
have more OPMD related bacteria groups while 
Proteobacteria was found to have more cancer 
related bacteria groups.  Besides that, around 
half of the bacteria groups in Actinobacteria 
were found to be associated with both diseased 
conditions.
Community structure of oral microbiota
AMOVA results (Table 7) indicated that the 
significant genetic variations between all subject 
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groups were due to the variations observed 
between normal and cancer groups. Although 
the genetic structure of bacteria diversity in the 
OPMD group was not significantly different from 
that of normal or cancer groups, two-dimensional 
NMDS plot showed that the bacteria community 
groups associated with OPMD subjects were 
sandwiched between that of normal and cancer 
subjects (Fig. 5). The 0.12 stress level indicated 
that the two-dimensional NMDS plot was a good 
representation of the similarities of the different 
oral microbiome communities. NMDS plot 
based on ethnicity and gender shows no distinct 
variations among different oral conditions (Figs. 
6 & 7). This finding is in agreement with Nasidze 
et al (2009) in which no association between 
gender and age on oral microbial communities 
was mentioned.
FIG. 5: Two Dimensional NMDS Plot with three groups of oral microbial communities
FIG. 7: Two Dimensional NMDS Plot of oral micro-
bial communities with association of different 
genders
FIG. 6:  Two Dimensional NMDS Plot of oral 
microbial communities with association of 
Chinese, Indian and Malay ethnicity
DISCUSSION
The core human oral microbiome
This study was able to identify five reported 
major oral microbiome phyla.41,42 The five 
bacterial phyla identified in this study (Fig. 2)
were consistently reported as the main oral 
microbiome components in both healthy and 
diseased states such as oral cancer, halitosis 
and periodontitis.15,31,33,43  With the exception of 
Lachnoanaerobaculum, bacterial genera that were 
identified in all the three oral conditions were also 
commonly reported in other cancer associated 
oral microbiome studies (Fig. 3).15,24,25  However, 
Lachnoanaerobaculum was first isolated from 
human saliva and it was previously identified 
as Clostridiales bacterium by HMP-DACC and 
was also listed in the Human Oral Microbiome 
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Database (HOMD).44,45  This observation 
of consistent oral bacteria taxa suggests the 
presence of a common core oral microbiome 
in terms of genus and phylum levels across 
different oral states regardless of the detection 
methods such as culture46, 16S cloned library 
and Next Generation Sequencing.15,23-25,31,33,41-43
The oral microbiome diversity
The higher effective species number of Shannon 
Index of both OPMD and cancer groups as 
compared to the normal group (Table 5) suggests 
that diseased oral conditions harbour more 
diverse oral microbiome community.  This 
finding is in congruent with higher species 
diversity seen in diseased shallow and deep 
pockets of the oral cavities.47
 The community structure of the normal 
and cancer associated oral microbiome was 
significantly different from each other (Table 7) 
which was in agreement with what previously 
reported where the DGGE fingerprint profiles of 
this two groups formed two distinct clusters.24 
In addition, this study also characterized the 
OPMD associated oral microbiome community 
structure that was not reported previously. The 
OPMD associated bacteria communities were 
shown to overlapped between the normal and 
cancer associated communities (Fig. 5) which 
conforms well to the OPMD definition, which 
is the transition stage between normal mucosa 
cells and OSCC.48  This overlapping community 
membership could be the unique feature of 
OPMD associated oral microbiome and also the 
plausible reason of the insignificant differences 
found in the community structure between the 
OPMD and the other two groups (Table 7).
 
Oral microbiome membership associated with 
normal and OPMD and cancer oral cavities
The oral microflora diversity can be influenced 
by the host’s dietary pattern  and the sampling 
method of choice that could capture different 
sub-populations according to different targeted 
intraoral regions.16,33  Besides, the community 
membership pattern can also be influenced by 
the immunocompromised states of the cancer 
patients. However, despite these variations, 
several oral bacterial species in this study were 
identified to have consistent association with 
their respective microenvironment (Table 6). 
 Eubacterium saphenum and Selenomonas 
sputigena is among the members of healthy core 
oral microbiome which is consistently identified 
in normal oral tissues.15,23  On the other hand, 
Camplylobacter showae was more associated 
with cancer conditions since it was identified 
more in tumour tissues. It was reported that C. 
showae could coagulate with Fusobacterium 
nucleatum in some colon cancer cases.49 
 Several oral microbes were associated with 
diseased oral conditions as they were not only 
found in OPMD and cancer groups in this study 
but also isolated from oral tumour tissues from 
previous studies.  Catonella morbi was detected 
at higher amount in OSCC tissue samples.15 
Besides that, Rothia mucilaginosa  was found 
to be an emerging opportunistic pathogen due 
to frequent detection in immunocompromised 
hosts.50 In addition, R. dentocariosa was 
associated with dental caries & periodontitis 
and is rarely involved in clinical infection.51,52
 One of the major finding of this study is 
the identification of OPMD associated oral 
microbe, such as Megasphaera micronuciformis, 
Prevotella melaninogenica and P. veroralis, 
which could be potential biomarkers to 
detect this pre-cancerous transition stage. M. 
micronuciformis was first isolated from abscess 
samples and was found to be associated with 
immunocompromised HIV infected patients as 
an opportunist.53,54 P. melaninogenica was found 
to be a potential salivary marker for early oral 
cancer detection  besides being known as a 
periodontitis causal agent.23,55  On the other hand, 
P. veroralis was only known to be isolated from 
the human oral cavity.56  Nonetheless, it was 
reported that tumour tissues harboured higher 
amount of Prevotella species  which suggested 
a possible strong relationship between oral 
cancer and certain Prevotella species such as 
P. melaninogenica and P. veroralis.57
 OPMD associated oral microbes may appear 
as potential biomarkers of important medical 
value as these species allow the diagnosis of 
OPMD to be possible and may even permit early 
treatment interventions to occur before the start 
of oral cancer.  Early detection and treatment of 
oral cancer would result in great improvements 
on the treatment outcome and the survival 
rate.10,11  M. micronuciformis is potentially the 
best candidate for OPMD specific biomarker 
as it was detected only in the OPMD group in 
this study. Besides that, other oral microbes 
such as P. melaninogenica, P. veroralis, and R. 
mucilaginosa are also proposed to be possible 
biomarkers for early oral cancer detection as 
they were detected at higher abundance in 
OPMD oral conditions (Table 6).  In addition, 
the consistent association of Camplylobacter 
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showae with cancerous oral conditions (Table 
6) suggests that these oral microbes could be 
explored for other potential therapeutic values 
such as biomarkers for cancer prognosis  or as 
vectors for targeted treatment.58,59  
 This study only identified patterns of oral 
microbiome variation between oral cancer 
and normal individuals without identifying 
specific confounding factors such as their 
immunocompromised and inflamed states. 
Subsequently, the exact role of reported 
disease associated microbes remains unknown. 
Nonetheless, the bacteria species identified as 
potential biomarkers for diagnostic, prognosis 
and therapeutic purposes in this study would 
require further confirmations from thorough 
investigation involving larger sample size of 
patient subjects, particularly patients who are 
diagnosed with OPMD and had transformed 
into cancer over a period of time.
Conclusion
A core human oral microbiome, in terms of 
common bacterial phyla and genera, was observed 
in the oral samples of all three types of subjects 
(normal, OPMD and oral cancer patients). 
The normal and cancer associated general oral 
microbiome were significantly distinct from each 
other while the community membership of the 
OPMD associated oral microbiome was found 
to overlap between the normal and cancer oral 
microbiota.  Although microbiome diversity can 
be influenced by immunocompromised states and 
sampling methods, this study identified some 
consistent patterns that could have potential 
clinical applications. M. micronuciformis 
could be an important biomarker for early oral 
cancer detection due to its association only with 
the OPMD subjects. Besides that, other oral 
microbes with potential biomarker properties 
include P. melaninogenica, P. veroralis and R. 
mucilaginosa as they were identified at higher 
amount in OPMD groups.  Other bacteria species 
such as Camplylobacter showae could have other 
potential medical values in tumour management 
such as cancer prognosis and treatment strategies 
since they were consistently associated to the 
cancer group. The identification of OPMD 
associated oral microbiome and OTUs provided a 
more inclusive view on the relationship between 
oral cancer, oral microbes and microbiome 
community structure. However, the diagnostic 
or therapeutic values of these bacterial species 
and groups require further validations with higher 
number of OPMD and oral cancer samples.
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